Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.3K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.3K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

920
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
920
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

893
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
893
Hepatitis01:25

Hepatitis

42
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
42
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

493
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
493
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

1.1K
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
1.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Direct Oral Anticoagulant Type and Dose in Atrial Fibrillation With Decompensated Cirrhosis: A Propensity-Matched Analysis.

Gastro hep advances·2026
Same author

Do hepatic and biliary functional data from gadoxetate-enhanced MRI add value in predicting outcomes in primary sclerosing cholangitis (PSC)?

European radiology·2026
Same author

The Nutrition Landscape in Chronic Liver Disease.

Digestive diseases and sciences·2026
Same author

Vitamin B6 predicts poor outcomes in geographically distinct populations with primary sclerosing cholangitis.

Journal of hepatology·2026
Same author

Compositional and functional differences of gut microbiome and metabolome inform pathogenesis of cholestatic liver disease.

Gut microbes·2026
Same author

Gaps in Guideline Adherence for Primary Sclerosing Cholangitis in North America-A 5-Year Analysis.

Liver international : official journal of the International Association for the Study of the Liver·2026

相关实验视频

Updated: Apr 4, 2026

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

936

主要胆汁硬化

Elizabeth J Carey1, Ahmad H Ali1, Keith D Lindor2

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ, USA.

Lancet (London, England)
|September 15, 2015
PubMed
概括
此摘要是机器生成的。

主要胆汁硬化 (PBC) 是一种慢性肝病. 虽然ursodeoxycholic acid (UDCA) 改善了存活率,但对于没有反应的人来说,需要新的治疗方法,核受体激素显示出有前途.

更多相关视频

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

18.0K
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

16.8K

相关实验视频

Last Updated: Apr 4, 2026

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

936
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

18.0K
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

16.8K

科学领域:

  • 肝病学
  • 免疫学
  • 胃肠病学

背景情况:

  • 初级胆管硬化 (PBC) 是一种慢性胆固醇性肝病,其特征是自身免疫性小胆管的破坏.
  • 抗线粒体抗体 (AMA) 是一种特定的血清标志物,存在于约95%的PBC患者中.
  • 疲劳和是常见的症状,无论疾病的严重程度如何.

研究的目的:

  • 审查目前对PBC流行病学,病变和自然史的理解.
  • 讨论PBC目前的管理策略和并发症.
  • 介绍新兴的治疗方案,包括对核受体激素的研究.

主要方法:

  • 对原发性胆汁硬化现有文献的综述.
  • 临床试验数据的分析,以测试ursodeoxycholic acid (UDCA) 的疗效.
  • 对新型治疗点的研究成果的探索.

主要成果:

  • 在PBC患者中改善了无移植存活率.
  • 大约40%的PBC患者对UDCA的生化反应不足.
  • 肝脏移植为没有补偿的肝硬化患者提供了很好的结果.

结论:

  • 尽管UDCA有好处,但很大一部分PBC患者需要替代治疗.
  • 对核受体激素的研究为新的PBC疗法提供了有前途的途径.
  • 了解PBC的各个方面对于改善患者护理至关重要.